HB 3834
Approved by Governor 05/12/2026
Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.
- Oklahoma
- House / Assembly
- Introduced Feb 2, 2026
- Session 2026
Official Bill Page
Loading official bill page…
This state’s bills aren’t available here
Oklahoma’s legislature doesn’t allow its bill pages to be shown on other sites. You can read the full bill on the official page.
View on official siteLegislative Timeline
31 actions-
Approved by Governor 05/12/2026
-
Sent to Governor
-
Enrolled measure signed, returned to House
-
Enrolled, signed, to Senate
-
Referred for enrollment
-
Fourth Reading, Measure passed: Ayes: 69 Nays: 21
-
SA's read, adopted
-
SA's received
-
Engrossed to House
-
Referred for engrossment
-
Measure passed: Ayes: 33 Nays: 9
-
General Order, Considered
-
Placed on General Order
-
Reported Do Pass, amended by committee substitute Appropriations committee; CR filed
-
Referred to Appropriations
-
Reported Do Pass Health and Human Services committee; CR filed
-
Second Reading referred to Health and Human Services Committee then to Appropriations Committee
-
First Reading
-
Engrossed, signed, to Senate
-
Referred for engrossment
-
Third Reading, Measure passed: Ayes: 68 Nays: 23
-
Amended
-
General Order
-
CR; Do Pass Health and Human Services Oversight Committee
-
Authored by Senator Frix (principal Senate author)
-
Coauthored by Representative(s) Pae
-
Policy recommendation to the Health and Human Services Oversight committee; Do Pass Public Health
-
Referred to Public Health
-
Second Reading referred to Health and Human Services Oversight
-
Authored by Representative May
-
First Reading